We report a novel ionic liquid (IL)-mediated transcutaneous vaccine formulation consisting of a solid-in-oil nanodispersion of antigen coated with pharmaceutically accepted surfactants dispersed in IL-containing oil. The introduction of IL in the formulation significantly enhanced the skin permeability of ovalbumin, a model antigen.